Diffuse Large Cell Lymphoma

Diffuse Large Cell Lymphoma

In this, the second of three videos in which Sunita Nasta, MD, FACP reviews findings from ASH on the aggressive lymphomas, Dr. Nasta considers diffuse large B cell lymphomas (DLBCL). Among other advances, her presentation includes an overview of current investigational targeted therapies and a consideration of RCHOP therapies, as well as the introduction of two agents, a novel, oral dual inhibitor of histone deacetylas and P13K and venetoclax monotherapy, for patients with relapsed/refractory DLBCL.

To view other parts of this program:

Part 1: Mantle Cell Lymphoma

Part 3: T-Cell Lymphoma

 

 

Related Links


Published

December 7, 2016

Created by

Penn Physician VideoLink